Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265327 | 1.00 | LMNA (0.34) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6814043 | 1.00 | LMNA (0.34) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6813908 | 1.00 | LMNA (0.34) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6814750 | 1.00 | LMNA (0.34) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6813338 | 0.94 | LMNA (0.35) | LMNACYP1A2THPOKMT2A | |
| SCHEMBL6271636 | 0.87 | LMNA (0.40) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL4101354 | 0.86 | LMNA (0.39) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6270515 | 0.83 | LMNA (0.39) | LMNACYP1A2THPOGBA1MEN1 | |
| SCHEMBL6265711 | 0.83 | LMNA (0.31) | LMNACYP1A2THPO | |
| SCHEMBL6270119 | 0.83 | LMNA (0.48) | LMNACYP1A2THPOGBA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005092907-A2 | MONOSACCHARIDE DERIVATIVES AS ANTI-CANCER AND ANTI-INFLAMMATORY AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-10-06 | — | — | WO | disclosed |